Metabolic dysfunction and kidney disease risk in individuals with MAFLD by Ziyan Pan, Mohammed Eslam

Get full text

MASLD vs. MAFLD. A narrative review by Amedeo Lonardo, Ming-Hua Zheng, Mohammed Eslam

Get full text

Exploring the diagnostic accuracy of MAFLD, MASLD and metabolic syndrome in individuals with and without steatosis. by Mariana M. Ramírez-Mejía, Stephany M. Castañeda-Castillo, Mohammed Eslam, Nahum Méndez-Sánchez

Get full text

Energy metabolism: An emerging therapeutic frontier in liver fibrosis by Iram Irshad, Saleh A Alqahtani, Kenichi Ikejima, Ming-Lung Yu, Manuel Romero-Gomez, Mohammed Eslam

Get full text

HOMA-IR, an independent predictor of advanced liver fibrosis in metabolic-dysfunction associated fatty liver disease: a cross-sectional study in Egyptian patients by Yasser Fouad, Ziyan Pan, Shaymaa Nafady, Alaa M. Mostafa, Asmaa Bakr, Mahmoud Hagag, Ahmed Gomaa, Samy Zaky, Mohammed Eslam

Get full text

Characterisation of non-cirrhotic MAFLD-related hepatocellular carcinoma: a retrospective cohort study by Shadi Zerehpooshnesfchi, Fatema Safri, Ziyan Pan, Romario Nguyen, Lawrence Yuen, Vincent Lam, Christopher Nahm, Tony Pang, Golo Ahlenstiel, Jacob George, Mohammed Eslam, Liang Qiao

Get full text